blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3263104

EP3263104 - USE OF BGP15 TO STIMULATE MITOCHONDRIAL FUSION [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  30.11.2018
Database last updated on 30.09.2024
FormerThe application has been published
Status updated on  01.12.2017
Most recent event   Tooltip30.11.2018Application deemed to be withdrawnpublished on 02.01.2019  [2019/01]
Applicant(s)For all designated states
N-Gene Research Laboratories Inc.
575 Madison Avenue, 10th floor
New York, NY 10022 / US
[2018/01]
Inventor(s)01 / SUMEGI, Balazs
Homokko utca 7
7634 Pecs / HU
02 / MANDL, Jozsef
Victor Hugo utca 45
1132 Budapest / HU
 [2018/01]
Representative(s)Bianchetti & Minoja with Trevisan & Cuonzo IPS SRL
Via Plinio, 63
20129 Milano / IT
[N/P]
Former [2018/01]Bianchetti Bracco Minoja S.r.l.
Via Plinio, 63
20129 Milano / IT
Application number, filing date16177514.301.07.2016
[2018/01]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3263104
Date:03.01.2018
Language:EN
[2018/01]
Search report(s)(Supplementary) European search report - dispatched on:EP16.12.2016
ClassificationIPC:A61K31/4545, A61P9/04, A61P11/00, A61P27/02, A61P25/00, A61P25/02, A61P43/00
[2018/01]
CPC:
A61K31/4545 (EP); A61P11/00 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P27/02 (EP); A61P43/00 (EP);
A61P9/04 (EP) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/01]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:VERWENDUNG VON BGP15 ZUR STIMULIERUNG DER MITOCHONDRIALEN FUSION[2018/01]
English:USE OF BGP15 TO STIMULATE MITOCHONDRIAL FUSION[2018/01]
French:UTILISATION DE BGP15 POUR STIMULER LA FUSION MITOCHONDRIALE[2018/01]
Examination procedure04.07.2018Application deemed to be withdrawn, date of legal effect  [2019/01]
09.08.2018Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time  [2019/01]
Fees paidPenalty fee
Additional fee for renewal fee
31.07.201803   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XY]US6306878  (SUMEGI BALAZS [HU], et al) [X] 1,6-9 * column 3, line 26 - line 42 * * column 6, line 40 - line 44 * [Y] 1,6-11;
 [Y]WO9911624  (GUILFORD PHARM INC [US]) [Y] 1,3 * page 1, line 15 - line 17 *;
 [Y]  - TANAKA K I ET AL, "Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice", BIOCHEMICAL PHARMACOLOGY, ELSEVIER, US, vol. 80, no. 6, ISSN 0006-2952, (20100915), pages 920 - 931, (20100601), XP027143956 [Y] 1,2 * abstract *
 [Y]  - SAHABOGLU AYSE ET AL, "PARP inhibition: Could a target for cancer therapy also be a target for the treatment of Retinitis Pigmentosa?", INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE - IOVS, ASSOCIATION FOR RESEARCH IN VISION AND OPHTHALMOLOGY, US, (20150601), vol. 56, no. 7, ISSN 0146-0404, page 5461, XP009192593 [Y] 1,4 * the whole document *
 [I]  - GEETA SAPRA ET AL, "The small-molecule BGP-15 protects against heart failure and atrial fibrillation in mice", NATURE COMMUNICATIONS, (20141209), vol. 5, doi:10.1038/ncomms6705, page 5705, XP055243051 [I] 1,5 * abstract *

DOI:   http://dx.doi.org/10.1038/ncomms6705
 [Y]  - YOUNG MATTHEW J ET AL, "Human mitochondrial DNA replication machinery and disease", CURRENT OPINION IN GENETICS & DEVELOPMENT, (20160409), vol. 38, doi:10.1016/J.GDE.2016.03.005, ISSN 0959-437X, pages 52 - 62, XP029767524 [Y] 1,6-11 * abstract * * page 52, column right, line 5 - line 16 * * page 56, line 6, paragraph right - line 7 * * page 57, column left, lines 3-5, 45,-46 *

DOI:   http://dx.doi.org/10.1016/j.gde.2016.03.005
 [Y]  - WORKER C, "A NOVEL PARP INHIBITOR, ION CHANNEL MODULATION AND AD THERAPIES", IDRUGS,, (19990101), vol. 2, no. 9, ISSN 1369-7056, page 859/860, XP000865947 [Y] 1,3,4 * page 859, column left, lines 1-24 *
 [Y]  - EROGLU BINNUR ET AL, "Therapeutic inducers of the HSP70/HSP110 protect mice against traumatic brain injury", JOURNAL OF NEUROCHEMISTRY, (201409), vol. 130, no. 5, pages 626 - 641, XP002764703 [Y] 1,2 * abstract * * page 635, column right, line 17 *
by applicantWO2005123049
    - ADAMSON IY ET AL., AM J PATHOL, (1974), vol. 77, pages 185 - 197
    - AL-MERJAN JI ET AL., OPHTHALMIC EPIDEMIOL, (2005), vol. 12, pages 251 - 257
    - ANDREUX PA ET AL., NAT REV DRUG DISCOV., (201306), vol. 12, no. 6, pages 465 - 83
    - ARDUINI ET AL., J. AM J PHYSIOL GASTROINTEST LIVER PHYSIOL., (201107), vol. 301, no. L, pages G119 - 27
    - ASHCROFT ET AL., J CLIN PATHOL, (1988), vol. 41, pages 467 - 470
    - BOSTAN A ET AL., AUTON NEUROSCI., (20120925), vol. 170, no. 1-2, pages 70 - 2
    - BOWEN ET AL., EUR J HEART FAIL., (201503), vol. 17, no. 3, pages 263 - 72
    - BUCH H ET AL., OPHTHALMOLOGY, (2004), vol. 111, pages 53 - 61
    - CHANG ET AL., J BIOL CHEM., (20140321), vol. 289, no. 12, pages 8337 - 52
    - CHENG ET AL., ACTA PHARMACOL SIN., (201307), vol. 34, no. 7, pages 951 - 9
    - DARIN ET AL., ANN NEUROL., (200103), vol. 49, no. 3, pages 377 - 83
    - ELACHOURI ET AL., GENOME RES., (201101), vol. 21, no. 1, pages 12 - 20
    - FARKAS ET AL., BIOCHEMICAL PHARMACOLOGY, (2002), vol. 63, pages 921 - 932
    - FLEISCHMAN RW ET AL., THORAX, (1971), vol. 26, pages 675 - 682
    - FRICK KD ET AL., ARCH. OPHTHALMOL, (2012), vol. 130, pages 629 - 634
    - GIACOMOTTO ET AL., HUM MOL GENET, (20131115), vol. 22, no. 22, pages 4562 - 78
    - HALMOSI ET AL., MOLECULAR PHARMACOLOGY, (2001), vol. 59, no. 6, pages 1497 - 1505
    - HATA H ET AL., JPN. J. OPHTHALMOL, (2003), vol. 57, pages 259 - 262
    - HORI ET AL., GENES CELLS., (201105), vol. 16, no. 5, pages 527 - 44
    - KIJAS JW ET AL., PROC. NATL. ACAD. SCI. U.S.A., (2002), vol. 99, pages 6328 - 6333
    - KUNDU S ET AL., INT MED J, (2013), vol. 20, page 34
    - LESTIENNE ET AL., BIOMED PHARMACOTHER., (1994), vol. 48, no. 5-6, pages 199 - 214
    - LOVY ET AL., J VIS EXP., (20120720), page E3991
    - MAARSINGH H ET AL., "Naunyn Schmiedebergs", ARCH PHARMACOL., (200808), vol. 378, no. 2, pages 171 - 84
    - MARC RE ET AL., MOL. VIS., (2008), vol. 14, pages 782 - 806
    - MEERSSEMAN ET AL., GENE, (20140301), vol. 537, no. 1, pages 154 - 63
    - MIHAYLOVA V ET AL., J NEUROGENET., (201306), vol. 27, no. 1-2, pages 19 - 22
    - MISHRA ET AL., NAT REV MOL CELL BIOL., (201410), vol. 15, no. 10, pages 634 - 46
    - NAASH ML ET AL., INVEST. OPHTHALMOL. VIS. SCI., (1996), vol. 37, pages 775 - 782
    - NAGY ET AL., TOXICOLOGY AND APPLIED PHARMACOLOGY, (2010), vol. 243, pages 96 - 103
    - NASRALLAH CM ET AL., NAT REV ENDOCRINOL., (201411), vol. 10, no. 1 1, pages 650 - 8
    - OZAKI ET AL., BIOCHIM BIOPHYS ACTA, (201211), vol. 1822, no. 11, pages 1783 - 95
    - PAPANICOLAOU ET AL., AM J PHYSIOL HEART CIRC PHYSIOL., (20120801), vol. 303, no. 3, pages H243 - 55
    - PARAMASIVAM A ET AL., MITOCHONDRION, (201601), vol. 26, pages 81 - 5
    - PASKOWITZ ET AL., BR. J. OPHTHALMOL, (2006), vol. 90, pages 1060 - 1066
    - PLAFKER ET AL., INT REV CELL MOL BIOL, (2012), vol. 298, pages 135 - 77
    - REDMANN ET AL., INT J BIOCHEM CELL BIOL., (201408), vol. 53, pages 127 - 33
    - ROSSI L ET AL., BLOOD CELLS MOL DIS, (2004), vol. 33, pages 57 - 63
    - RUTAR M ET AL., CURR. EYE RES., (2010), vol. 35, pages 631 - 643
    - RUTAR M ET AL., INVEST. OPHTHALMOL. VIS. SCI., (2011), vol. 52, pages 5347 - 5358
    - SCHWARZER ET AL., J PHYSIOL., (20140901), vol. 592, no. 17, pages 3767 - 82
    - SHARMA ET AL., CIRC HEART FAIL., (201604), vol. 9, no. 4, page E002639
    - SZABADOS ET AL., BIOCHEMICAL PHARMACOLOGY, (2000), vol. 59, pages 937 - 945
    - SZCZEPANOWSKA ET AL., BIOCHIM BIOPHYS ACTA, (201210), vol. 1817, no. 10, pages 1740 - 6
    - WANG ET AL., J BIOL CHEM., (20150102), vol. 290, no. 1, pages 168 - 82
    - WENZEL A ET AL., PROG. RETIN. EYE RES., (2005), vol. 24, pages 275 - 306
    - WERT ET AL., Cell-Based Therapy for Retinal Degenerative Disease. Dev Ophthalmol, (2014), vol. 53, pages 33 - 43
    - WU ET AL., DEVELOPMENT, (2015), vol. 142, pages 681 - 691
    - YOUNG ET AL., CURR OPIN GENET DEV., (20160408), vol. 38, pages 52 - 62
    - ZANONI I ET AL., NATURE, (20090709), vol. 460, no. 7252, pages 264 - 8
    - ZORZANO ET AL., FRONT AGING NEUROSCI, (20150610), vol. 7, page 101
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.